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INTRODUCTION
With the development of digital imaging capabilities, the emergence of multiplane TEE, 
and cine loop review, TEE has improved visualization of the coronary artery tree and enhanced 
detection of its abnormalities. Although TEE is unlikely to replace coronary angiography as the 
primary imaging modality in coronary artery disease, published reports over the past 12 years 
have defined a role for TEE in coronary artery disease.
Although the diagnosis of ostial stenosis of the left main coronary artery usually is made 
by coronary angiography, positioning of the catheter across the obstruction may obscure this 
diagnosis during the contrast injection. Several authors have reported cases in which TEE was 
able to make a correct diagnosis in patients with possible left main coronary artery stenosis, in 
whom damping of the left main coronary artery wave form during catheterization did not allow 
differentiation of significant left main artery.
The diagnosis of left main coronary artery disease is important in the management of 
patients  with  symptomatic  coronary  artery  disease.  TEE  can  be  considered  when  cardiac 
catheterization suggests  ostial  stenosis  but angiography is  inconclusive.  The diagnosis  of  a 
proximal  stenosis  may  be  confirmed  by  direct  visualization  of  the  area  of  narrowing  and 
supported by color flow Doppler demonstration of flow aliasing.
Recent advances in TEE have enabled the direct evaluation of coronary flow especially 
in the proximal and mid LAD where the culprit lesion of AWMI is present. TEE can potentially 
enable direct evaluation of coronary perfusion at a site just distal to culprit lesion in AWMI. 
We hypothesized that good reperfusion would be associated with less reduction in coronary 
flow and therefore would have better  ante grade flow visualization by color TEE and less 
reduced ante grade flow velocity by pulsed TEE.
Atherosclerotic plaque tends to occur focally typically in a certain predisposed regions 
while sparing adjacent segments. They are scatter along the entire aorta and its main branches 
e.g. coronary, renal and cerebral vessels.
The  close  proximity  of  the  TEE probe  to  the  thoracic  aorta  allows  high  frequency 
imaging  of  the  intraluminal  structures  including  detection  of  atherosclerotic  plaque. 
Atherosclerotic aortic plaque detected by TEE could be used as a marker for coronary artery 
disease.
      In this study we are using TEE to evaluate coronary artery disease by visualizing the 
proximal left coronary artery, the flow velocity in LAD, and the presence of atherosclerotic 
plaque in descending thoracic aorta. 
AIM
1.  Visualization  and measurement  of  the  size  of  Left  main  coronary  in  patients  with 
coronary artery disease by Transesophageal echocardiography.
2.  Measurement  of  blood  flow  velocity  in  Left  main  and  Proximal  Left  Anterior 
Descending  artery  in  patients  with  coronary  artery  disease  by  Transesophageal 
echocardiography.
3.  Measurement of intimal thickness and presence of plaque and its size in descending 
thoracic  aorta  in  patients  with  coronary  artery  disease  by  Transesophageal 
echocardiography. 
REVIEW OF LITERATURE
Weyman et al first reported the use of two-dimensional transthoracic echocardiography 
to visualize the coronary arteries more than 20 years ago. In adults, surface imaging provides 
morphologic information usually limited to the proximal left coronary artery and the origin of 
the right coronary artery.
Zwicky  et  al first  reported  the  use  of  trans-esophageal  echocardiography  (TEE)  to 
evaluate  the  coronary  arteries.  The  advantages  of  the  transesophageal  approach  over  the 
transthoracic approach in coronary artery imaging include the absence of anatomic obstacles 
between the ultrasound transducer and the aortic root and better resolution characteristics using 
higher-frequency (7-MHz) transducers. 
The  use  of  color  flow  Doppler  mapping  and  spectral  Doppler  echocardiography  to 
measure coronary artery flow velocities during TEE was first reported by Yamagishi et al.
With TEE, the coronary arteries are visualized primarily in the short-axis plane at a 
transducer  angle  of  0°.  The  normally  placed  ostium  of  the  left  main  coronary  artery  is 
visualized with the transducer positioned just above the aortic cusps and rotated slightly to the 
left. The left main coronary artery, arising from the corresponding sinus, is usually 0.5 to 2.5 
cm in length. Small adjustments in the transducer orientation are often necessary to view the 
vessel along its full length from the aortic root to its bifurcation. The bifurcation is usually Y-
shaped with the left anterior descending (LAD) artery coursing to wards the apex and the left 
circumflex in the atrioventricular groove. Further adjustments in transducer orientation may be 
required to optimize visualization of the proximal left anterior descending coronary artery. The 
color flow Doppler signal in the LAD can be used to guide placement of the pulsed Doppler 
sample volume for flow velocity interrogation.
Normally, the ostium of the right coronary artery arises at the 7 0'clock position on the 
short-axis view of the aorta and is visualized as the probe is withdrawn 1 to 2 cm above the 
level of the aortic valve and is flexed anteriorly. Further anterior flexion permits visualization 
of the right coronary artery as it courses downward and to the right. The right coronary ostia 
and 1 to 2 cm segment of the proximal right coronary artery also can be visualized in the 
longitudinal  plane  typically  at  110°  to  130°  of  rotation.  Minor  angle  adjustments  of  the 
multiplane  may  facilitate  imaging  of  the  coronary  arteries.  Color  flow  Doppler  flow 
interrogation of the right coronary artery is possible; however, spectral Doppler is usually not 
possible because of suboptimal beam orientation.
Two-dimensional  imaging of  the  left  main  coronary  artery  is  enhanced by  the  near 
perpendicular alignment of the ultrasound beam with the left  main coronary artery, relying 
primarily on axial resolution. Proper gain adjustment is crucial to imaging and operators should 
be  careful  not  to  under  gain  the  images.  The  color-coded  Doppler  flow pattern  may  help 
identify pathology of the coronary arteries. Appropriate Nyquist limits for color flow Doppler 
mapping in the coronary arteries are in the range of 0.5 meter per second. If the Nyquist limits 
are set inappropriately low, areas of flow aliasing may be evident in the absence of stenosis, 
potentially increasing the number of false positives. With these caveats, color flow channel 
delineation of narrowing increases the sensitivity and specificity of the diagnosis of a stenosis. 
In the study Yoshida et al using biplane TEE, sensitivity was 91% and specificity 100% 
for the detection of proximal coronary artery luminal narrowing. Negative predictive accuracy 
was  98%  and  positive  predictive  accuracy  100%.  In  the  studies  by  Tradif  et  al and 
Khandheria  et  al using  multiplane  TEE,  the  sensitivity  and  specificity  for  detection  of 
proximal  coronary  narrowing  were  100%  when  the  results  were  compared  with  the 
angiographic data.
Pulsed Doppler and color Doppler echocardiography combined with TEE can be used to 
measure  the  velocity  of  the  proximal  coronary  artery  blood  flow.  The  left  main  and  left 
circumflex  coronary  arteries  are  nearly  perpendicular  to  the  echo  beam,  whereas  the  left 
anterior descending coronary arteries are nearly parallel  to it.  The velocity measurement is 
dependent on the position of the sample volume in relation to the coronary luminal narrowing. 
The velocity is normal proximal to the stenosis,  increased within the stenosis,  and reduced 
distally.  TEE  also  can  noninvasively  evaluate  the  functional  results  of  the  left  anterior 
descending coronary  artery  after  an angioplasty.  TEE can evaluate  the  stenosis  of  the  just 
proximal portion of the right coronary artery; however, because the right coronary artery is not 
parallel to the echo beam and highly movable, it is very difficult to measure the flow velocities.
Yamagishi et al reported that  coronary blood flow could be detected and measured 
during TEE in only 77% of patients.  The development of multiplane TEE and intravenous 
contrast agents has increased the efficacy of TEE. Coronary flow velocity is best measured 
with pulsed Doppler interrogation of the very proximal segment of the left anterior descending 
coronary  artery.  Flow  measurements  in  the  right  coronary  artery  are  limited.  Because  of 
transitional  motion,  the  left  anterior  descending  coronary  artery  does  not  lie  in  the  same 
position  throughout  the  entire  cardiac  cycle.  The  position  of  the  left  anterior  descending 
coronary artery is more stable in diastole.
Doppler sample volume using the position of the vessel is in diastole. The probe angle 
and sample volume are adjusted in order to orient the Doppler signal parallel to coronary flow. 
Color flow can aid in positioning of the pulsed Doppler sample volume.
The  characteristic  normal  flow  pattern  within  the  left  anterior  descending  coronary 
artery consists of a minor systolic flow signal and a major diastolic signal due to extra vascular 
compression   during  systole  component.  This  flow  pattern  is  very  similar  to  that  of  the 
Doppler-tip catheter or Doppler-tip guide wire. The basal coronary flow pattern is influenced 
by the presence of cardiac disease. Patients with severe aortic stenosis have a depressed systolic 
coronary flow velocity. This abnormal systolic component of coronary flow velocity in severe 
aortic stenosis may result from reduced aortic pressure during systole. For example, patients 
with  long-standing  hypertension,  with  or  without  left  ventricular  hypertrophy,  have  higher 
baseline coronary flow velocities. These high velocities may result in increased intimal shear 
stress. Because coronary flow is physiologically predominant during diastole, it is unlikely that 
a reduction in systolic flow alone may result in myocardial ischemia.
Baseline coronary flow velocity is an important determinant of the CFR. The normal 
range of  baseline diastolic  velocity  of  coronary artery flow is  less  than 60 centimeters  per 
second.  Patients  with  higher  basal  coronary  flow may  have  diminished  CFR.  Using  TEE, 
Memmola et  al demonstrated altered coronary  flow dynamics  in  patients  with obstructive 
hypertrophic cardiomyopathy. Reduced or reversed systolic and increased diastolic coronary 
flow velocity with consequently higher diastolic and systolic coronary flow velocity ratio were 
associated with impaired coronary flow reserve. Kisanuki et al showed reduced CFR during 
systole and diastole in patients with moderate-to-severe chronic aortic regurgitation compared 
with  the  control  group.  Similarly,  in  these  patients,  baseline  coronary  flow  velocity  was 
increased.
With technical advancements, including high frequency, multiplane transducers, digital 
acquisition and display, and left-sided contrast agents, TEE is emerging as a promising method 
for evaluating coronary artery disease. Visualization of proximal coronary artery stenoses and 
coronary artery anomalies is already possible. Research studies using TEE measurement have 
contributed  to  under  standing coronary  artery  physiology and may prove to  be  a  valuable 
clinical tool in the future.
TEE would also enable the non invasive differentiation of TIMI-3 flow from TIMI 2 in 
patients with AWMI in acute phase. Mere presence of antegrade flow in proximal left coronary 
generally indicates TIMI 2 or 3 flow. In patients with TIMI 3 flow the LAD flow velocity is 
present with even it may be increased.
Intra coronary Doppler guidewire studies showed that coronary blood flow velocity is 
preserved or even increased in patients with TIMI 3 flow with a diastolic peak velocity of 36 ± 
11 cm/sec whereas flow velocity is reduced in patients with TIMI 0 to 2 flow. Therefore for 
most patients TIMI 3 flow can be diagnosed on the basis of higher peak diastolic LAD flow 
velocity TIMI 2 or less by low flow velocity.
Coronary artery atherosclerosis is the principal cause of coronary artery disease and is 
the single largest killer of both men and women in the world . A major recent advance has been 
a refined understanding of the nature of atherosclerotic plaque and the phenomenon of plaque 
rupture, which is the prime cause of acute coronary syndrome (ACS) and AMI. In many cases 
(perhaps more than half), the plaque that ruptures and results in the clinical syndromes of ACS 
and AMI is less than 50% occlusive. These so-called vulnerable plaques, as compared with 
stable plaques, consist of a large lipid core and thin, fibrous caps and are subjected to greater 
biomechanical stress, thus leading to rupture that perpetuates thrombosis and ACS.
Coronary artery atherosclerosis or CAD refers to the presence of atherosclerotic changes 
within the walls of the coronary arteries, which causes impairment or obstruction of normal 
blood flow with resultant  myocardial  ischemia.  CAD is  a  progressive  disease  process  that 
generally  begins  in  childhood  and  manifests  clinically  in  mid-to-late  adulthood.  The 
distribution of lipid and connective tissue in the atherosclerotic lesions determines whether they 
are stable or at risk of rupture, thrombosis, and clinical sequelae. 
A healthy endothelial layer is thrombo resistant because of the production of heparin 
sulfate and eicosanoids, which inhibit thrombin activation and platelet adhesion, respectively. 
Endothelial  cells  also  produce  relaxation  factors  (eg,  endothelium-derived  relaxing  factor 
[EDRF] or nitric oxide) and vasoconstricting factors (endothelin) that affect the resting tone of 
the underlying media containing several layers of smooth muscle cells (SMCs). The media are 
bound on the outside by an external elastic lamina that separates them from the adventitia, 
which  consists  mainly  of  fibroblasts,  SMCs,  and  a  matrix  containing  collagen  and 
proteoglycans.
Over the past decade,  Fuster et al and colleagues have proposed that vascular injury 
starts the atherosclerotic process. According to their response-to-vascular injury theory, injury 
to the endothelium by local disturbances of blood flow at angulated or branch points, along 
with  systemic  risk  factors  (eg,  hyperglycemia,  dyslipidemia,  cigarette  smoking,  possibly 
infection) perpetuates a series of events that culminate in the development of atherosclerotic 
plaque.
Atherosclerotic plaque may require 10-15 years for full development. Further growth is 
determined  by  the  local  activity  of  regulatory  substances  (ie,  interleukin  (IL)–1,  IL-6, 
transforming  growth  factor-beta)  and  by  thrombin,  leukotriene,  prostaglandin,  fibrin,  and 
fibrinogen.
Although a logical conclusion is that the most severely stenotic lesions are the ones at 
the greatest risk of sudden occlusion, this is not the case. As previously described, ACS has 
been shown to more often develop because of rupture and thrombosis of mild (<60%) coronary 
stenoses. This occurs because of the relatively higher lipid content of the lipid core, the thinner 
fibrous cap, and the increased leukocyte activity at the shoulder regions of the plaque. These 
characteristics make such plaques, called the vulnerable plaques, much more prone to rupture.
Mechanisms of the effects of risk factors
The  presence  of  risk  factors  accelerates  the  rate  of  development  of  atherosclerosis. 
Smoking  increases  platelet  activity  and  catecholamine  levels,  alters  prostaglandins,  and 
decreases high-density lipoprotein (HDL) levels. Hypertension causes endothelial dysfunction 
and  increases  collagen,  elastin,  and  endothelial  permeability  and  platelet  and  monocyte 
accumulation.  Diabetes  causes  endothelial  dysfunction,  decreases  endothelial  thrombo-
resistance, and increases platelet activity, thus accelerating atherosclerosis.
Plaque growth and vascular remodeling
As endothelial  injury and inflammation progress,  fibroatheromas grow and form the 
plaque. As the plaque grows, 2 types of remodeling occur,  (1) positive remodeling and (2) 
negative remodeling.
Positive remodeling
Positive remodeling is an outward compensatory remodeling (the Glagov phenomenon) 
in which the arterial wall bulges outward and the lumen remains uncompromised. Such plaques 
grow  further,  although  they  usually  do  not  cause  angina  because  they  do  not  become 
hemodynamically significant for a long time. In fact, the plaque does not begin to encroach on 
the lumen until it occupies 40% of the cross-sectional area. The encroachment must be 70% or 
greater to cause flow limitation. Such positively remodeled lesions thus form the bulk of the 
vulnerable plaques, grow for years, and are more prone to result in plaque rupture and ACS 
than stable angina, as documented by intravascular ultrasound (IVUS) studies.
Negative remodeling
Many fewer lesions exhibit almost no compensatory vascular dilation, and the atheroma 
steadily grows inward, causing gradual luminal narrowing. Many of the plaques with initial 
positive remodeling eventually progress to the negative remodeling stage, causing narrowing of 
the vascular lumen. Such plaques usually lead to the development of stable angina. They are 
also vulnerable to plaque rupture and thrombosis.
Eruption of the vulnerable plaque
Tight coronary atheromas rarely cause ACS and MI. In fact, most of the atheromas that 
cause ACS are less than 50% occlusive as demonstrated by coronary arteriography. Atheromas 
(plaques) with smaller obstruction experience greater wall  tension, which changes in direct 
proportion to their radii. Most plaque ruptures occur because of disruption of the fibrous cap, 
which  allows  contact  between  the  highly  thrombogenic  lipid  core  and  the  blood.  These 
modestly obstructive plaques, which have a greater burden of soft lipid core and thinner fibrous 
caps  with  chemoactive  cellular  infiltration  near  the  shoulder  region,  are  called  vulnerable 
plaques. The amount of collagen in the fibrous cap depends on the balance between synthesis 
and destruction of intercellular matrix and inflammatory cell activation.
Imaging Studies
Transthoracic echocardiography helps to assess left  ventricular function, wall motion 
abnormalities  in  the  setting  of  ACS  or  AMI,  and  mechanical  complications  of  AMI. 
Transesophageal echocardiography is most often used for assessing possible aortic dissection in 
the  setting  of  AMI.  Stress  echocardiography  can  be  used  to  evaluate  hemodynamically 
significant  stenoses  in  stable  patients  who  are  thought  to  have  CAD.  Treadmill 
echocardiography  stress  testing  and  dobutamine  echocardiography  stress  testing  provide 
equivalent predictive values.
Nuclear  imaging studies (myocardial  perfusion imaging) are also useful  in assessing 
patients  for  hemodynamically  significant  coronary  artery  stenoses.  Stress  and  rest  nuclear 
scintigraphic  studies  using  thallium,  sestamibi,  or  teboroxime  are  sometimes  helpful. 
Radionuclide  stress  myocardial  perfusion  imaging  can  be  used  to  quantify  coronary  flow 
reserve (CFR).  Likewise Magnetic resonance angiography and Electron beam CT scanning 
plays significant role in imaging coronaries in this setup.
Coronary  angiography  remains  the  criterion  standard  for  defining  significant  flow-
limiting stenoses that must be revascularized through percutaneous or surgical intervention to 
improve prognosis. Quantitative coronary angiography (QCA) is used to perform computerized 
quantitative  analysis  of  the  entire  coronary  tree.  It  introduces  a  correction  factor  for  the 
presence  of  diffuse  disease.  QCA has  been  widely  used  in  many  trials  of  atherosclerotic 
progression and regression.
Limitations of coronary arteriography are as follows: 
Severity of stenosis is generally estimated visually, but estimation is limited by the fact 
that interobserver variability may range from 30-60%. The presence of diffuse disease also may 
lead to underestimation of stenoses because the stenosed areas are expressed as a percent of 
luminal diameter compared with adjacent normal coronary segments and in diffuse disease, no 
such segments exist. This usually occurs in diabetic patients, in whom coronary arteries are 
traditionally described as small-caliber vessels,  when that appearance is actually due to the 
presence of diffuse symmetrical involvement of the entire vessel, as elucidated by recent IVUS 
studies.
Because of the inherent limitations of coronary angiography, attention has been directed 
to using physiological approaches for determining the severity of coronary stenoses. 
The 5 methods of measuring human coronary blood flow in the cardiac catheterization 
laboratory are (1) thermodilution, (2) digital subtraction angiography, (3) electromagnetic flow 
meters,  (4)  Doppler  velocity  probes  (for  measuring  CFR),  and  (5)  pressure  wires  (for 
measuring fractional flow reserve [FFR]).  Although most current methods measure relative 
changes in coronary blood flow, useful  information about the physiological  significance of 
stenosis, cardiac hypertrophy, and pharmacological interventions can be obtained from these 
measurements. 
Doppler velocity probes use a Doppler flow meter, which is based on the principle of the 
Doppler  effect.  This  is  the  most  widely  applied technique for  measuring coronary  flow in 
humans. High-frequency sound waves are reflected from moving red blood cells and undergo a 
shift in sound frequency proportional to the velocity of the blood flow. 
In pulsed-wave Doppler methods, a single piezoelectric crystal can both transmit and 
receive high-frequency sound waves. These methods have been successfully applied in humans 
by using miniaturized crystals fixed to the tip of catheters. Technological developments have 
further miniaturized steerable 12-MHz Doppler guidewires to a diameter of 0.014 inches.
Flow due to a stenosis can therefore be assessed distally and proximally. The Doppler 
guidewire measures phasic flow velocity patterns and tracks linearly with flow rates in small, 
straight coronary arteries.
Indications  for  Doppler  velocity  probe  use  include  determining  the  severity  of 
intermediate  stenosis  (40-60%)  and  for  evaluating  whether  normal  blood  flow  has  been 
restored after PTCA. The use of smaller Doppler catheters allows measurement of selective 
coronary artery flow velocity. By noting the increase in flow velocity following administration 
of a strong coronary vasodilator, such as papaverine or adenosine, the CFR can be defined. 
CFR provides an index of the functional significance of coronary lesions that obviates some of 
the ambiguity of anatomical description.
The  current  Doppler  probe  method has  limitations.  Limitations  include  (1)  only 
changes in flow velocity, rather than absolute velocity or volumetric flow, are measurable; (2) 
the change in flow velocity is directly proportional to changes in volumetric flow only when 
vessel dimensions are constant at the site of the sample volume; (3) other factors, including left 
ventricular  hypertrophy  and  myocardial  scarring,  can  also  affect  CFR;  and (4)  changes  in 
luminal  diameter  and  arterial  cross-sectional  area  during  interventions  are  not  reflected  in 
measurements of flow velocity, thus potentially causing underestimation of the true volume 
flow.
Basic Concepts
Spectrum Analysis 
 If blood flow were continuous rather than pulsatile, if blood vessels followed straight 
lines and were uniform in caliber, if blood flowed at the same velocity at the periphery as well 
as in the center of the lumen, and if vessels were disease free, then each blood vessel would 
produce a single Doppler ultrasound frequency. However, blood flow is pulsatile, vessels are 
not always straight or uniform in size, flow is slower at the periphery than in the center of the 
vessel, and the vessel lumen may be distorted by atherosclerosis and other pathology.
For  these  reasons,  blood  flow  produces  a  mixture  of  Doppler  frequency  shifts  that 
changes from moment to moment and from place to place within the vessel lumen. 
Spectrum analysis is needed to sort out the jumble of Doppler frequencies generated by 
blood flow and to provide quantitative information that is critical for diagnosis of vascular 
pathology.
The Doppler Spectrum 
The word spectrum, as derived from Latin, means image. Doppler spectrum as an image 
is a graph showing the mixture of Doppler frequencies present in a small area of a vessel over a 
short period of time. The key elements of the Doppler spectrum are time, frequency, velocity 
and Doppler signal power.
The Power Spectrum 
Doppler frequency spectrum is some times called a power spectrum, because the power, 
or strength of each frequency is shown by the brightness of the pixels. The power of a given 
frequency  shift,  in  turn,  is  proportionate  to  the  number  of  red  blood  cells  producing  that 
frequency  shift.  If  a  large  number  of  blood  cells  are  moving  at  a  certain  velocity,  the 
corresponding Doppler frequency shift is powerful, and the pixels assigned to that frequency 
are bright. Conversely, if only a small number of cells are causing a certain frequency shift, the 
pixels assigned to that frequency are dim.
Frequency versus Velocity 
The echoes  that  return  to  the  transducer  from a  blood  vessel  contain  only  Doppler 
frequency shift information; yet the Doppler spectrum often displays both velocity (cm/sec or 
m/sec) and frequency (kHz) information. 
If  the  instrument  “knows”  the  Doppler  angle,  it  can  then  compute  the  blood  flow 
velocity via the Doppler formula. When the operator informs the ultrasound machine of this 
angle,  the  frequency  shift  is  proportional  to  blood  flow velocity.  The  frequency  spectrum 
becomes a velocity spectrum. It is generally recommended that the Doppler angle should be 
between 45 and 60 degrees for greatest accuracy.
The Doppler frequency shift observed in a tortuous artery might be radically different 
from  one  point  to  another,  but  angle-corrected  velocity  measurements  will  be  similar 
throughout the vessel, in spite of dramatic changes in vessel orientation relative to the skin. To 
determine  stenosis  severity,  different  diagnostic  parameters  would  be  needed  for  different 
ultrasound transducers (e.g., 3.5, 5, or 7.5 MHz).
The sample volume  
The frequency spectrum shows blood flow information from a specific location called 
the  Doppler  sample  volume and the  following are  the  three  characteristics  of  the  Doppler 
sample volume. First, it is in fact, a volume (three dimensions), even though only two of its 
dimensions are shown on the duplex image. The “thickness” of the sample volume cannot be 
shown on the two-dimensional  spectrum display,  and this  can sometimes lead to  errors  of 
localization.  Second,  the  actual  shape  and  size  of  the  sample  volume  may  be  somewhat 
different from the linear representation shown on the duplex image. Third, and most important, 
the Doppler spectrum display flow information only within the sample volume and does not 
provide information about flow in other portions of the blood vessel that are visible on the 
ultrasound image.
Flow Direction 
The  frequency  spectrum  shows  blood  flow  relative  to  the  transducer.  Flow  in  one 
direction, with respect to the transducer, is displayed above the spectrum baseline, and flow in 
the  opposite  direction  is  shown  below  the  baseline.  The  flow  direction  is  relative  to  the 
transducer and is not absolute. When accurate determination of flow direction is necessary, a 
comparison should be made with a reference vessel in which the flow direction is known.
In arteries,  each cycle of cardiac activity produces a distinct “wave” on the Doppler 
frequency spectrum that begins with systole and terminates at the end of diastole. The term 
waveform refers to the shape of each of these waves, and this shape, in turn, defines a very 
important flow property called pulsatility.
Low-pulsatility  Doppler  waveforms  have  broad  systolic  peaks  and  forward  flow 
throughout diastole. The carotid,  vertebral,  renal, and celiac arteries all have low-pulsatility 
waveforms  in  normal  individuals  because  these  vessels  feed  circulatory  systems  with  low 
resistance to flow.
Moderate pulsatility Doppler waveforms have an appearance somewhere between the 
low and high resistance pattern. With moderate flow resistance, the systolic peak is tall and 
sharp, but forward flow is present throughout diastole (perhaps interrupted by early-diastolic 
flow reversal). Examples of moderate pulsatility are found in the external carotid artery and the 
superior mesenteric artery .
High  –  pulsatility  Doppler  waveforms  have  tall,  narrow,  sharp  systolic  peaks  and 
reversed or absent diastolic flow. The classic example of high pulsatility is the triphasic flow 
pattern seen in an extremity artery of a resting individual.
Pulsatility and flow resistance may be gauged qualitatively, either by visual inspection of the 
Doppler spectrum waveforms or by listening to the auditory output of a Doppler instrument. 
Qualitative assessment of pulsatility is often sufficient for clinical vascular diagnosis, but in 
some  situations  (e.g.,  assessment  of  renal  transplant  rejection),  quantitative  assessment  is 
desirable.  A variety  of  mathematical  formulae  can  be  used  for  this  purpose,  but  the  most 
popular measurements are the pulsatility index (of gosling), the resistivity index (of Pourcelot), 
and the systolic/diastolic ratio. 
Both physiology and pathology may alter  arterial  pulsatility  proper  interpretation  of 
pulsatility requires knowledge of the normal waveform characteristics of a given vessel and the 
physiologic status of the circulation at the time of examination. The status of cardiac function is 
also  important;  showed  ventricular  emptying,  valvular  reflux,  valvular  stenosis,  and  other 
factors may significantly affect arterial pulsatility.
Severe  arterial  obstruction  is  present  proximal  (upstream)  to  the  point  of  Doppler 
examination, systolic flow acceleration may be slowed substantially.
Laminar and Disturbed Flow
Blood generally flows through arteries in an orderly way, with blood in the center of the 
vessel moving faster than the blood at the periphery. This flow pattern is described as laminar, 
because the movement of blood is in parallel lines. When flow is laminar, the great majority of 
blood cells are moving at a uniform speed, and the Doppler spectrum shows a thin line that 
outlines a clear space called the spectral window. 
In  disturbed flow,  the  movement  of  blood cells  is  less  uniform and orderly  than in 
laminar flow. Disturbed flow is manifested as spectral broadening or widening of the spectral 
waveform.  The  degree  of  spectral  broadening  is  proportionate  to  the  severity  of  the  flow 
disturbance.  Although  disturbed  blood  flow  often  indicates  vascular  disease,  it  must  be 
recognized that  flow disturbances also occur  in  normal vessels.  Kinks,  curves,  and arterial 
branching may produce normal flow disturbances.
Volume Flow
This  is  done  by  measuring  the  average  flow velocity  across  the  entire  lumen while 
simultaneously measuring the vessel diameter, which is converted mathematically into cross-
sectional area. Knowing the average velocity and the vessel area, it is an easy matter for the 
Doppler instrument to calculate the blood flow (in ml /min), and this is done automatically by 
the ultrasound instrument.
Five main categories of information are used in this process: (1) increased setnotic zone 
velocity, (2) disturbed flow in the poststenotic zone, (3) Proximal pulsatility changes, (4) distal 
pulsatility changes, and (5) indirect effects of obstruction, such as collateralization. 
Increased Stenotic Zone Velocity 
The  term  stenotic  zone  refers  to  the  narrowed  portion  of  the  arterial  lumen.  For 
determining  the  severity  of  arterial  stenosis,  the  single  most  valuable  Doppler  finding  is 
increased velocity in the stenotic zone. Flow velocity is increased in the stenotic zone because 
blood must move more quickly if the same volume is to flow through the narrowed lumer as 
through the larger, normal lumen. The increase in stenotic zone velocity is directly proportional 
to the severity of luminal narrowing.
Three stenotic zone velocity measurements are commonly used to determine the severity 
of arterial stenosis: (1) peak systolic velocity (also called peak systole), which is the highest 
systolic velocity within the stenosis; (2) end-diastolic velocity (also called end diastole), which 
is the highest end-diastolic velocity; and (3) the systolic velocity ratio, which compares peak 
systole in the stenosis with peak systole proximal to the stenosis (in a normal portion of the 
vessels).
                    
          Peak systole in the stenotic zone is the first Doppler parameter to become abnormal as an 
arterial lumen becomes narrowed. The region of maximum velocity within the stenotic zone 
may be quite small, and for that reason, the sonographer must “search” the stenotic lumen with 
the  sample  volume  to  locate  the  highest  flow  velocity.  If  the  highest  flow  velocity  is 
overlooked,  the degree of stenosis  may be underestimated.  As shown in peak systole rises 
steadily with progressive narrowing, but ultimately the flow resistance becomes so high 9at 
about 80% diameter reduction) that peak systole falls to normal or even subnormal levels. This 
drop in velocity can cause the unwary to underestimate the severity of a high-grade stenosis. 
Low flow velocity in a very high-grade stenosis may also lead to false diagnosis of arterial 
occlusion, if the velocity is so low that Doppler signals cannot be detected with ultrasound.
The end-diastolic velocity (end diastole) in the stenotic zone, generally remains normal 
with less than 50% (diameter) narrowing, as there is not pressure gradient across the stenosis in 
diastole. With moderate stenosis (505-70% diameter reduction), however, a pressure gradient 
exists  throughout  diastole,  and  end-diastolic  velocity  is  elevated  in  proportion  to  stenosis 
severity. With severe stenosis (70%-90% diameter reduction), a substantial pressure gradient 
exists throughout diastole, and diastolic velocities are high. Furthermore, with progression of 
stenosis severity, end diastolic velocity increases at a greater rate, proportionately, than the 
peak systolic velocity, and as a result, the difference between peak systolic and end-diastolic 
velocity decreases. End-diastolic velocity, therefore, is a particularly good marker for severe 
stenosis.
The systolic velocity ratio, as defined previously, is an additional important parameter 
for the diagnosis of arterial stenosis. This parameter is used to compensate for patient-to-patient 
hemodynamic  variables,  such  as  cardiac  function,  heart  rate,  blood  pressure,  and  arterial 
compliance,  Tachycardia,  for  instance,  tends  to  increase  peak systole  in  the  stenotic  zone, 
whereas poor myocardial function may decrease peak systole. The systolic velocity ratio allows 
the patient to act as his or her own physiologic “standard,” because peak systole in the stenotic 
zone is compared with peak systole in a normal arterial segment.
The post-stenotic zone is the region immediately beyond an arterial stenosis in which 
disorganized or “disturbed” flow occurs. Flow is disturbed in the post-stenotic region because 
the  flow stream from the  stenotic  lumen suddenly spreading out  in  the much larger,  post-
stenotic zone, causing the laminar flow pattern to be lost and the flow to become disorganized, 
which generates a disturbed Doppler spectral pattern. The maximal flow disturbance occurs 
within 1cm beyond the stenosis, and in very severe stenosis, soft tissues adjacent to this portion 
of the artery may vibrate, causing a “visible bruit” on color Doppler images. Approximately 
2cm beyond the stenosis, the flow disturbance becomes less violent and spectral broadening 
diminishes.  Severe flow disturbances are “beacons” indicating the presence of arterial disease.
Arterial obstruction causes increased pulsatility (as defined previously) in portions of the 
artery  proximal  to  (upstream from)  the  stenosis,  and  this  finding,  therefore,  may  be  very 
important diagnostically.           
In systole, flow will go forward for only a brief moment and will then slow abruptly; 
therefore, the systolic peak will be sharp and narrow. The increase in pulsatility proximal to a 
stenosis may be lessened in the presence of collateral flow.
Doppler  waveform  abnormalities  seen  distal  to  a  stenosis  (downstream)  also  have 
considerable value in the diagnosis of arterial stenosis. The flow velocity in a normal, wide 
open, artery increases abruptly in systole, and the systolic peak is reached quickly. The Doppler 
waveform distal to a severe arterial obstruction has a “damped” appearance. Which means that 
the acceleration is slowed there are three causes. First, it can be imagined that blood is being 
“squeezed” slowly through the obstructed lumen (or tiny collaterals), rather than “flying” along 
a broad tube. Therefore, it takes longer to reach peak velocity. Second, flow velocity is low, 
because less blood is moving through the obstructed vessel. This makes the Doppler waveform 
smaller  than normal  overall.  Finally,  ischemic distal  tissues  are  “begging”  for  blood,  with 
capillary beds wide open. The resultant decrease in peripheral resistance allows blood to flow 
with low velocity. The net effect of all three factors is the damped (also called dampened) 
waveform appearance. 
DIAGNOSIS  OF  UNSUCCESSFUL  THROMBOLYSIS  AFTER  ACUTE 
MYOCARDIAL INFARCTION
Trials  of  thrombolysis  and  primary  angioplasty  haves  shown  that  coronary  artery 
patency and flow characteristics following thrombolytic  therapy are independent prognostic 
predictors of the outcome in acute myocardial infarction(AMI). A number of studies suggest 
that the patency rates with TIMI 3 flow can not be achieved in more than 54% of patients even 
with the best  thrombolytic  regimen.  The timely detection of this  failed reperfusion is  very 
important for the further rational management of patients with AMI. The need is to diagnose it 
accurately  and  cost  effectively  preferably  using  non-invasive  techniques.  This  has  to  be 
followed  by  prompt  and  efficient  measures  to  attempt  reperfuse  these  blocked  vessels  by 
pharmacological, catheter based or combined strategies.
Cessation of chest pain has been regarded as a clinically predictive sign of reperfusion 
though its quantification for clinical trials is difficult. Only complete resolution of chest pain is 
a good predictor and this sign has been reported only in 29% patients with patent arteries. 
Analgesia which is an important part of the management of AMI can mask this sign. It  is 
therefore necessary to have more objectively defined markers along with resolution of chest 
pain.
Reperfusion Arrhythmias although observed frequently after thrombolysis and primary 
PTCA, none of the observed arrhythmias  such as accelerated idioventricular rhythm have been 
shown to add independently to the predictive value of diagnosing reperfusion.
Non  resolution  of  ST-segment  changes  after  thrombolysis  has  been  shown  to  be  a 
predictor of worse long-term outcome compared with the cohort with good resolution. This 
analysis  is  a  better  predictor  of  successful  perfusion  than  failed  reperfusion.  Studies  have 
shown  a  variety  of  ECG  indices  for  reperfusion  failed  or  success.  These  included  25% 
reduction  in  ST-segment  elevation  identified  in  the  'worst  lead'  on  the  60-180  min  post 
thrombolytic ECG, the pre to post thrombolysis ECG of maximal ST segment elevation ratio or 
the sums of post to pre-thrombolysis ST-segment elevation that is equal or less than  0.5. All 
these indices have been described as having reasonable sensitivity and specificity, irrespective 
of the infarct site . Continuous ST segment monitoring has also been shown to have a good 
predictive value for non reperfusion in GUSTO-I study especially when the initial ST segment 
elevation is more than 4 mm.
Of the numerous markers Creatinine kinase , isoenzymes troponin-T or I and myoglobin 
measurements have been used extensively for the early diagnosis of AMI. The rapid peaking of 
myoglobin seems to be the earliest marker of a successful  recanalization, while the rate of 
troponin-T rise over 3 hours post-thrombolysis has revealed very high(94%) sensitivity as well 
as specificity (100%) in this situation. There is however limited evidence that any of these 
markers can predict failure to achieve TIMI-3 flow at 60-90 mins with any degree of similar 
accuracy. At present these assays are mostly reserved for post hoc confirmation rather than 
direct decision, so that they may not help in the tirage of patients with failed reperfusion. Early 
peaking of levels of these markers while suggesting restoration of flow doesnot necessarily 
mean achievement of reperfusion at tissue level (restoration of micro vascular reperfusion). The 
failure of the accuracy and interpretation makes their  reliable use difficult  in the setting of 
failed reperfusion, especially in the absence of concomitant ST segment resolution.
There  is  some  evidence  to  suggest  that  patients  who  fail  to  achieve  detectable 
fibrinogenolysis  following thrombolysis  could benefit  from additional  thrombolysis.  In  one 
small study, benefit  was confined to those patients whose fibrinogen remained at greater level 
following therapy with streptokinase'. Although fibrinogen assay is not routinely tested, this 
measurement is potentially advantageous for distinguishing patients in whom non reperfusion 
is primarily due to non-fibrinogenolysis rather than due to no reflow. In such cases it would 
suggest  that  further  thrombolysis  and/or  intensified  antiplatelet  therapy  rather  than 
interventional treatment may be beneficial.
Emerging Diagnostic Strategies
Even  though  Sesta  Mffll  has  good  accuracy  in  assessing  patency  after  systemic 
thrombolysis,  the  need  to  obtain  pre  thrombolytic  scans  preclude  this  method  from  wide 
clinical application. The acute assessment of micro vascular perfusion by myocardial contrast 
echocardiography may be the  most  promising strategy.  Contrast  agents  are  currently  being 
tested in pre clinical  trials and are likely to become available for  clinical  trial  assessment 
shortly.
      There is no proven strategy which is clearly superior and can be recommended as the 
treatment  of  choice.  In  the  absence  of  sound  clinical  data  it  however  seems  logical  to 
recommend  a  careful,  frequent  assessment  of  the  patient's  clinical  status  after  instituting 
systemic  thrombolysis.  This  should  include  frequent  12  lead  ECG control.  A  90-120  run 
recording is very important which could form a basis for consideration for further management 
which could be PCI after administering Gp llb/IIIa blockers, if the option is easily achievable. 
It is likely that patients with failed thrombolysis comprise a heterogeneous group with different 
levels of failed lysis, micro vascular no reflow or different degrees of critical narrowing in the 
target or infarct related vessel. Careful evaluation of these factors in the individual patients will 
result in a more tailored and tiered approach.
Thrombus burden as a cause of TIMI-2 flow.  
A potential  problem in the treatment  of AMI is  a  possibility of distal  embolization, 
which may be even more important  during catheter-based treatment   The consequences  of 
coronary embolism depend on the size (and number) of emboli. The smaller the embolus, the 
greater  the  chance that  it  will migrate  distally  to  a  small  artery  and the  less  likelihood of 
myocardial necrosis. For particle sizes ranging from 15 to 45 µm, baseline blood flow into the 
embolized  area  may  actually increase  secondary  to  reactive  hyperemia  in  the  myocardium 
surrounding the embolized regions Conversely, the larger the embolic particle, the greater the 
chance that it will lodge proximally in a large coronary artery and result in ischemic myocardial 
necrosis. Coronary arterial resistance increases if massive embolization of the coronary arterial 
bed occurs. 
Recently, Gregorini  et  al reported  that  coronary  intervention  might also  cause 
neurohormonal reflexes and vasoconstriction, thus provoking a reduction in coronary blood 
flow velocity in patients with AMI. If coronary resistance could play an important role, it is 
likely that an increase in coronary resistance might even abate over time and, therefore, might 
possibly manifest as a transient phenomenon.
A rapid deceleration of diastolic CBFV is another characteristic of capillary damage. 
The  intra  myocardial  blood  volume  decreases with  damage  to  the  capillaries  and/or  post 
capillary venules. If the coronary inflow exceeds the capacitance, an impeding effect occurs on 
the diastolic coronary inflow by altering peri vascular strains, resulting in a rapid decrease in 
CBFV. This finding is also supported by recent findings that a shorter diastolic deceleration 
time is associated with poorer tissue perfusion and worse functional outcomes. 
Atherosclerosis of the Aorta:
Risk Factor, Risk Marker, or Innocent Bystander?
Atherosclerosis is a diffuse process, it is not surprising that multiple studies have found 
an association between aortic atherosclerosis and CAD. Extrapolation of these studies to the 
general population is misleading due to study limitations which include the highly selected 
nature  of  patient  groups  having  TEE  and  coronary  angiography  for  specific  clinical 
indications .Several authors have shown a strong association between aortic atherosclerosis and 
other risk factors for stroke. Age, hypertension, atrial fibrillation, carotid artery disease, and 
diabetes mellitus are well-known risk factors  for  cardiac events  and stroke.  These findings 
challenge  previously  drawn  conclusions  about  the  cause-and-effect  relationship  of  aortic 
atherosclerosis and clinical outcome. 
In  the  Stroke  Prevention  in  Atrial  Fibrillation  (SPAF)  III  trial,  complex  aortic 
atherosclerosis emerged as a significant independent predictor for stroke  and CAD without 
adjusting  for  age.  Age  has  been  shown  to  be  a  strong  independent  predictor  of  aortic 
atherosclerosis which suggests that atherosclerosis may be a marker of aging rather than a true 
risk factor for stroke or CAD. One autopsy study concluded that the presence of moderate or 
severe aortic atherosclerosis did not predict ischemic stroke subtype. Complex atherosclerosis 
is a high-risk marker in high-risk patients, but it is also a marker of many other risk factors for 
stroke or CAD, so a cause-and-effect relationship cannot be established This SPARC study is 
the  largest  prospective  population  based  TEE  study  published  to  date.  However,  size 
limitations imposed by the use of an invasive study in a relatively healthy population sample 
may have limited the ability of the SPARC study to detect a statistically significant hazard for 
the less prevalent risk factors.
Aortic atherosclerosis is increasingly detected with more frequent use of TEE. It does 
not appear to be an independent risk factor or a risk marker for vascular events in the general 
population.
MATERALS AND METHODS
Study Design
This study was conducted to observe the role of Transesophageal echocardiography in 
assessing the CAD by measuring the size and blood flow pattern in proximal left coronary and 
to visualize and detect the presence plaque in descending thoracic aorta.
Total Number of Patients
There were totally hundred and six (106) patients were included in this study.
Place of Study
This study was conducted in Government  Rajaji  Hospital  Madurai,  hundred and six 
(106) patients who were admitted in ICCU and fulfilled the inclusion criteria were selected for 
this study.
Study Period
This study was conducted from January 2006 to January 2008.
Inclusion Criteria
Patients who presented with acute anterior wall myocardial infarction were taken for this 
study.
All the patients were thrombolysed with intravenous streptokinase.
Exclusion Criteria
1. Patients with acute inferior wall infarction and unstable angina were excluded from this 
study.
2. Patients with symptoms of cardiac failure were excluded. 
3. Patients  with  H/o.  recurrent  episode  of  tachyarrhythmia  and  brady  arrhythmia  were 
excluded.
4. Patients  with  ongoing  chest  pain,  uncontrolled  hypertension  and  any  sign  of  active 
infection were excluded.
5. Patients older than sixty five years were excluded.
6. Patient with H/o upper GI bleed were excluded.
7. Patient who were not willing for Transesophageal study were excluded from the study.
Patient Characteristics
Among the total number of 106 patients, 86 patients were male and 20 patients were 
female. All the patients were presented with acute anterior wall myocardial infarction with an 
average median delay of 5 hours and 30  mts
All were thrombolysed with intravenous streptokinase 1.5 million units over a period of 
sixty minutes.
Surface ECG
Surface  ECG was  taken to  all  the  patients.  ECG was  analyzed  for  the  presence  of 
anterior wall myocardial infarction. Subsequently serial ECGs were taken. The lead in which 
there was maximal ST elevation was noted. The percentage of this ST segment resolution after 
90 minutes of thrombolysis was observed to document successful thrombolysis. Less than fifty 
percent resolution of maximal ST segment elevation at 90 minutes after thrombolysis was taken 
as unsuccessful or failed thrombolysis.
Trans thoracic Echocardiogram
In all the patients 2D, M mode, and Doppler examination were done by transthoracic 
echocardiogram. Left ventricular internal dimensions, wall thickness, ejection fraction and wall 
motion abnormalities were recorded and analyzed in all patients.
Equipment
In our study we used ALOKA - SSD - 4000 system with multiplane Transesophageal 
echocardiographic probe. It generated two dimensional images at multiple frequencies (5 to 7.5 
MHZ).
Instrumentation
In multiplane TEE the ultrasound beam was steered through 180 degree with physical 
manipulation by turning the appropriate knobs at the proximal end of the probe. An icon on the 
screen of the ultrasound machine in the form of semi circle. An needle like indicator in that 
semi circle array was steered. By convention 0 degrees will  be shown on the left  and 180 
degree on the right of the semi circle. The needle moved in a counter clockwise direction when 
the beam was guided from 0 to 180 degrees.
The multiplane probe was interfaced to a standard ultrasound imaging console. Piloting 
to ultrasound beam in this fashion provides continuous visualization of the transition between 
adjacent structures which improves the operator understanding of the spatial relationship of the 
cardiac structure.
Procedure
 The patient was instructed not to eat in the proceeding 8 hours other than taking important 
medication with a sip of water.
 Informed consent was obtained in all the patients.
 Topical oropharygeal anesthesia with 2% lignocaine viscous was given to all the patients. 
Patients were instructed to gargle and keep it in the throat for 10-to 20 minutes.
 If  the  patient  was  very  anxious,  conscious  sedation  achieved  with  1  to  2  mg  of   Inj. 
Midazolam. 
 The patient  was then positioned in the left  lateral  decubitous position with head flexed 
forward into the chest. This position of the neck was important because it eased out the 
passage of the probe into esophagus. The hip and knees were flexed. 
 Dentures if any were removed and the oropharynx was inspected in detail for loose teeth or 
other abnormalities.
 Intravenous access was obtained in all the patients.
 Oxygen saturation,  blood pressure and cardiac rhythm were monitored and oxygen was 
given via nasal prong in select patients.
 Prior to starting the procedure the probe was inspected for any damage to the outer layer to 
prevent electrical and thermal injuries.
 The distal and of the probe was lubricated with lignocaine jelly and the bite block was 
inserted between teeth. The tip of the probe was partially flexed.
 The left index finger guide the probe avoiding entry into the lateral recesses with the right 
hand the probe was inserted into the mouth over the surface of the tongue in the midline 
toward the back of the throat.
 The patient was asked to swallow with gentle downward pressure applied at the same time 
using the finger to guide the scope keeps probe in midline and direct it toward the posterior 
pharyngeal wall and the upper esophageal sphincter. 
 Using the control dial the scope was forced anteriorly, to negotiate the turn around the back 
of  the tongue.  Once the scope has passed from the oropharynx to the upper esophagus 
sphincter the probe then turned to the neutral or slightly retroflexed position to avoid the 
trachea inlet.  
 The patient was asked to swallow and as the patient was swallowing scope was gently 
advanced through the upper esophagus sphincter. Swallowing enabled the sphincter to relax 
and  gentle  forward  pressure  on  the  shaft  of  the  probe.  Simultaneously  resulted  in  the 
successful esophageal intubation.
 The probe was then advanced to about 30 to 40 cm from the teeth (incisors). Only minimal 
resistance should encounter in at the upper esophageal sphincter prior to its relaxation and 
passage  of  scope  in  the  esophagus.  Any  unusual  resistance  or  bowing  of  the  scope 
suggested obstruction and the scope should be withdrawn and intubation reattempted. At no 
time the probe should be forced. 
 The standard images were obtained from within stomach followed by as the probe was 
withdrawn into esophagus.
 An orderly sequence was followed for a complete study. First from the distal gastric fundus 
and  then  by  stepwise  withdrawal  and  imaging  the  probe  was  brought  back  to  upper 
esophagus. At each transducer location the imaging beam was stared from O to 180 degrees 
in 15 degrees increment. Complete two dimensional sweep was followed by relevant color 
flow Doppler imaging.
 In our study a short axis view at the aortic level was obtained by rotating the image plane 
between 30° and 45° and withdrew the probe from lower esophagus to mid esophagus at 
aortic level.
 The origin of left main coronary artery was easily identified after minor adjustments in the 
depth and tilt of image plane. The right coronary artery was more difficult to visualize.
 At this position the following observations were made
1. Visualization of left Main, proximal left anterior descending artery and, proximal left 
circumflex artery and proximal right coronary artery.
2. Size, the peak and mean blood flow velocities in both diastole and systole in left main 
and proximal left anterior descending artery. 
From the transesophageal or transgastric position  the transducer was turned in either 
direction until the image plane was directed slightly left of the patient spine to obtain short axis 
view of the descending thoracic aorta. The aorta appeared circle and showed normal systolic 
pulsations.
TEE examination of the descending thoracic aorta was performed in all the 106 patients 
to find out the presence of atherosclerotic plaque. The thoracic aorta was considered normal 
when the intimal surface was smooth and continuous without luminal irregularities or echo 
destiny. If the intimal surface was increased in echo density but remained smooth and continue 
with luminal irregularities it  was defined as grade 1. Intimal thickness less than 5mm with 
higher echogenic area disrupting the normal smooth surface of the vessel wall and cause lumen 
irregularities was classified as Grade II. Grade III changes consist of intimal thickness more 
than  5mm and  or  obvious  lumen  irregularities  associated  with  localized  highly  echogenic 
mobile lesion protruding into the vessel lumen Grade II and Grade III lesions were considered 
to  be  atherosclerotic  aortic  plaque.  Grade  I  lesions  on  would  have  a  potential  to  develop 
atherosclerotic plaque.
The following observations were made at this position. 
1. The size the descending aorta 
2. Intimal thickness
3. Presence of atherosclerotic plaque and its size.
RESULTS
This  study  demonstrated  high  quality  imaging  of  left  main  coronary  artery  and 
measurement  of  luminal  diameter  by  using  transesophageal  echocardiography.  Statistical 
analysis were done by using student T test and Chi Square test.
Among total number of 106 patients with acute myocardial infarction who underwent 
thrombolysis  with Inj.Streptokinase satisfactory  examination of full  length of  the  left  main 
coronary were obtained in all (100%) the patients. In addition to left main coronary artery the 
origin and proximal portion of LAD was seen in 98 of 106 patients (93%) and proximal portion 
of LCX was seen in 92 of 106 patients (87%). Proximal RCA was visualized in 31 of 106 
patients (29%).
The mean diameter of the left main coronary was 0.39 ± 0.06cm; Proximal LAD mean 
diameter was 0.30 ± 0.04 cm; Proximal left circumflex mean diameter was 0.27± 0.11cm.
The  mean length  of  the  left  main  coronary  was  0.99  ±0.30cm;  proximal  LAD was 
2.2±0.77cm and proximal left circumflex was 2.7±1.1cm. 28 patients of 106 showed significant 
narrowing of left coronary artery. 
Among these 28 patients 6 patients showed narrowing of left main coronary artery, the 
rest 22 patients showed narrowing of proximal of LAD. The mean diameter and length in those 
patients with left main narrowing were 0.24±0.14 cm and 0.86± 0.31cm respectively.
Coronary flow velocity  could  be  measured in  98 of  106 patients  (92%).  It  was  not 
possible to get Doppler flow velocity signal accurately in 8 patients.
The following velocity profile was taken as normal value (in cm / sec).
LM LAD LCX RCA
Diastole Peak - 49 ± 20 40 ± 15 37 ± 12Mean 71 ± 19 31 ± 15 25 ± 8 26 ± 7
Systole Mean 36 ± 11 23 ± 11 21 ± 6 21 ± 9
28  patients  in  whom  significant  coronary  artery  narrowing  was  visualized  by  TEE 
showed turbulence across narrowed site. Both peak and mean diastolic flow velocities were 
increased  in  these  patients.  Mean  and  peak  coronary  flow  velocity  in  patients  with  LM 
narrowing were 1.22±0.17 m/sec and 1.52 ± 0.2 m/sec respectively against 0.42 ± 0.35 m/sec 
and 0.55 ±0.4 m/sec of patients without LM disease and 0.92±0.38 m/sec and 1.12± 0.42 m/sec 
in patients with LAD narrowing against 0.34± 0.29 an m/sec and 0.46± 0.35 m/sec in patients 
without  LAD  narrowing.  Average  peak  and  mean  velocities  of  combined  LM  and  LAD 
narrowing were1.2± 0.38 m/sec 0.99± 0.37 m/sec respectively as compared to 0.37 ±0.16 m/sec 
and 0.27 ±0.13 m/sec in patients without narrowing.
Risk factor analysis showed 21 of 106 patients were hypertensives and 37 of 106 were 
diabetic.  Hypercholesterolemia was present in 8 patients.  Family history of coronary artery 
disease  was  obtained  in  15  patients.  55  of  106  patients  were  smokers.  21  patients  were 
associated with two on more risk factors.
21 out of 28 patients with significant left coronary artery narrowing were having two or 
more risk factors (4 of 6 with left main narrowing and 15 of 21 with narrowing of proximal 
LAD).
ECG analysis showed presence of RBBB in 19 patients. 10 of 28 patients who showed 
increased turbulence in the left  main and proximal LAD had RBBB. Rest of 78 patients 9 
patients showed RBBB at the time of presentation. 1 of 4 patients who had LBBB showed left 
main narrowing. 3, 2 and 4 of 106 patients developed first, second and third degree heart block 
respectively but none of them showed proximal left coronary narrowing or turbulence. Atrial 
fibrillation was present in 2 patients. 29 patients had non sustained VT . 13 of these 29 patients 
with  NSVT showed  coronary  artery  narrowing.  20  were  in  the  successfully  thrombolysed 
group, 9 patients were in the unsuccessful thrombolysis group.
Transthoracic 2D echo showed ejection fraction ranging from 0.19 to 0.55. The mean 
ejection  fraction  was  0.32..  Mitral  regurgitation  was  present  in  38  of  106  patients.  Left 
ventricular thrombus was present in 11 patients. Pericardial effusion was present in  5 patients.
28 patients  with significant  narrowing of  left  main and LAD 10 patients  had mitral 
regurgitation.  Mild pericardial  effusion was present in 5 patients.  Thrombus was seen in 4 
patients.
106  patients  who  were  thrombolysed  with  Inj.  Streptokinase  were  divided  into  two 
groups. First group had 67 patients who were successfully thrombolysed and 39 patients in the 
second group who had unsuccessful thrombolysis. The average coronary blood flow velocity in 
the  first  group  was  0.78  ±0.42  m/sec  (peak)  0.62±  0.37m/sec  (mean  )  and  it  was  0.34  ± 
0.27m/sec(peak) and 0.24 ±0.11m/sec (mean) in  the second group.    
Out of 106 patients in our study we could do CAG for 48 patients.  5 patients showed 
normal  coronaries  and  43  patients  had  CAD (Single  Vessel  Disease  -25  ;  Double  Vessel 
Disease -8 ; Triple Vessel Disease -7 ; LMD -3 ) Among 6 patients with LM narrowing by 
TEE, 3 patients underwent CAG and all the three had LM stenosis . 19 patients with LAD 
narrowing  by  TEE  underwent  CAG  out  of  which  15  had  proximal  LAD  narrowing 
angiographically.
80 patients of 106 in our study showed atherosclerotic plaque. The average length of the 
plaque was 2.9 cm ± 0.06 cm and the average width was 0.55 ± 0.06 cm. The average intimal 
thickness was 0.3 ± 0.06 mm. 
26 and 13 of 80 patients with thoracic aortic plaque were diabetics and hypertensives 
respectively. Family history of coronary artery disease was present in 11 of 80 patients, 7 of 80 
patients  had hypercholesterolemia.  48 of  80 were smokers.  Two or more  risk factors  were 
present in 17 patients.
Among 43 patients with angiographically proven CAD, 34 patients had thoracic aortic 
plaque  by  TEE  and  9  patients  did  not  show  any  plaque.  Out  of  5  patients  with  normal 
coronaries by CAG 3 patients had aortic plaque and 2 patients showed no aortic plaque by 
TEE.  
DISCUSSION
We subjected 106 patients with anterior wall myocardial infarction who were admitted 
in ICCU at GRH Madurai from January 2006 to January 2008. The principle aim of out study 
was to find out the ability of transesophageal echocardiography to visualize left main, proximal 
left anterior descending and proximal left circumflex coronary artery and to measure the size of 
left  main  coronary  artery.  We also  aimed at  measuring  the  blood flow velocities  in  these 
arteries. 
The descending thoracic aorta was visualized in all the patients to find out the presence 
or absence of atherosclerotic plaque and if it was present its size and intimal thickness. We also 
looked for any correlation between atherosclerotic  plaque in descending thoracic aorta as a 
marker of coronary artery disease.
The evaluation of coronary artery is  challenging because of the size and location of 
these  vessels.  The left  main and right  coronary  arteries  and the  proximal  segments  of  left 
anterior  descending  and  left  circumflex  arteries  can  be  visualized  during  transesophageal 
echocardiography in most patients.
Youn  HJ  &  Foster  E et  al in  their  study  found  out  that  using  high  frequency 
multiplanar  and digital  acquisition  and display  with  or  without  contrast  agent  would  be  a 
promising method for evaluating coronary artery disease by visualizing the proximal coronary 
artery stenosis and coronary artery anomalies. They claimed TEE would be a valuable clinical 
tool  in  measuring  coronary  blood  flow  and  contributed  to  understand  coronary  artery 
physiology.
M.A. Taams et. al. in a prospective study with 22 patients who had angiographically 
proven left main coronary disease found both left main and left circumflex coronary arteries 
were visualized in all the patients (100%) but left anterior descending artery was visualized in 
only three patients (13%). Extent of left  main stenosis was correctly diagnosed in eighteen 
patients (78%).
In our study the visualization of left main and left anterior descending were 100% and 
94%  respectively.  The  visualization  of  LAD  was  94%  as  compared  Taams  et  al study 
population were it was only 13%.
K. Yoshida et al in their study obtained adequate images of full length of the left main 
coronary artery and its bifurcation in 90% (60 out of 67) of patients by using TEE. TEE could 
also able to find out significant coronary artery narrowing of the coronary lumen in 91% (10 
out  of  11).  Angiographically  proven left  main  stenosis  was  seen  in  11  out  of  60  patients 
(18.3%) Blood flow in left main coronary to left anterior descending artery was demonstrated 
in 85% (57 out of 67) by color Doppler.
In our study the significant left coronary narrowing was visualized in 28 patient out of 
106 (26%) almost similar to above study. According to Kasprzk J.D et al, TEE could visualize 
and measure blood flow in coronary ostia and proximal LAD in all (100 %) the patients which 
consist with our study.
160 consecutive patients were studied to assess the feasibility, sensitivity and specificity 
to visualize proximal coronaries by Memmola et al. The entire proximal left coronary artery 
was adequately imaged in 111 patients (70%). According to him stenosis was considered to be 
present  if  the  plaque  narrowing  of  the  coronary  lumen  were  observed.  He  identified  the 
presence of stenosis in 6 out of 6 (100%) 50 of 53 (79%) of angiographically proven left main 
and left anterior descending artery respectively. Then he found the sensitivity and specificity of 
TEE in identifying stenosis of LMCA and Proximal LAD were 100% and 98% and 79% and 
89% respectively. He concluded TEE identification of proximal LCA was feasible in most 
patients  and accuracy  in  identifying significant  proximal  stenosis  was  higher  for  left  main 
coronary artery.
J.C. Tardiff et al. performed intraoperative multiplane TEE for 45 consecutive adults. 
The left main and its bifurcation was visualised in all the patients sensitivity and specificity for 
detection  and  coronary  artery  narrowing  were  100%  when  results  were  compared  with 
angiographic data. Visualisation of proximal, mid and distal LAD segments were possible in 
69%, 31% and 16% of patients respectively. The sensitivity and specificity in visualizing, the 
significant narrowing in proximal LAD was 89% and 100%, and colour Doppler examination 
was found to be less useful in detecting stenosis in proximal LAD (52%).
Alam et al. in his study demonstrated left main coronary trunk in 30 of 32 patients by 
TEE. Of these 30 patients 10 had angiographically normal and 20 had stenosis of left main 
coronary  arteries.  The  TEE  study  revealed  no  stenosis  in  9  of  10  patients  without  LM 
narrowing and atherosclerotic lesion in all the patients with stenotic left main trunk (100%).
In our study 3 out of 6 patients with turbulence and increased flow velocity across LM 
underwent CAG and all of them (100%) had significant LM disease which correlated exactly 
with the study findings of Memmola et al. J.C. Tardiff et al. and Alam et al . It was nearly 
91% and 96% from the studies by  K. Yoshida et al  and Samdharshi TE et al respectively.
          Out of 22 patients with proximal LAD narrowing by TEE we did CAG for 19 patients 
and 15 (78.9 %) had proximal LAD lesion which was similar to the findings by Samdharshi 
TE et al where 11 (78%) of 14 patients showed stenoses involving the left anterior descending 
artery angiographically,
According to  Waller the length of Left main coronary ranged from 1 to 25mm before 
bifurcation into LAD and LCX branches. The total length of LAD coronary artery measured 
from 10 to 13cm whereas left circumflex measured 6 to 8 cm.
Samdharshi TE et al. evaluated proximal coronary artery in 111 consecutive patients 
intraoperatively  and  coronary  angiogram was  done  with  in  a  week.  Transesophageal  echo 
visualized the entire length of left main artery and it was 0.2 to 2.2 cm (Mean 0.93 cm). He 
could able to visualize the length 0.2 to 2.2 cm of proximal LAD and 0.1 to 3.4 cm of proximal 
LCX in 103 patients  (92%) and 0.1 to 4.5 cm of the proximal right coronary artery in 55 
patients (49%) from bifurcation.
Cheemalapathi  Saikrishna  et  al.  in  his  study  attempted  to  establish  and  normal 
dimensions of coronary artery segments during life in Indians and compared this with western 
population. In this study the mean diameter (in millimeters) of LMCA was 3.72 ± 0.65 in male 
and 2.72 ± 0.48 in female; Proximal LCX 2.82 ± 0.63 in males and 2.68 ± 0.59 in females. 
Proximal RCA 2.75 ± 0.6 in males and 2.55 ± 0.57 in females.
Kaimkhani  et  al. studied  coronary  artery  dimensions  in  Pakistani  population  and 
compared this with caucasians mentioned in the literature. The mean diameter (in millimeter) 
of LMCA was 4.28 ± 0.82; proximal LAD mean diameter was 3.22 ± 0.74 and the proximal 
LCX 3.02 ± 0.75; the mean diameter and RCA was found to be 3.08 ± 0.78.
In our study the mean length a left main was 0.99±  0.30 cm; the average length of 
visualized proximal LAD was 2.2 ±0.77 cm and proximal LCX was 2.78 ± 1.1cm correlates 
almost same with the finding of Samdharshi et al. The mean diameter (in cm) of Left main in 
this study was 0.39 ± 0.06; proximal LAD 0.30 ± 0.04 and Proximal LCX was 0.27 ± 0.11 
similar to the findings of the study by Saikrishna et al. 
R.Erbel et al. analysed coronary blood flow by TEE in his land mark paper and found 
that the velocity measurement was dependent on the position of the sample volume in relation 
to the coronary luminal narrowing. The velocity was normal proximal to the stenosis, increased 
with in the stenosis and reduced distally. Thus the anatomy of the artery had to be known to 
accurately measure coronary blood flow velocity. This was done effectively by TEE.
Fumihiko Kajiya et al. in his study evaluated post stenotic blood flow velocity in nine 
patients with 75% to 90% stenosis of LAD during CABG surgery. LAD blood flow velocities 
measured several location distal to the stenosis. The post stenotic blood flow velocities were 
reduced in their diastolic components with rich systolic component. The velocity configuration 
in the post stenotic portion was characterized by the presence of reverse flow velocities and 
irregularity of the velocity pattern near the wall.
In contrast, Takeshi et al. studied coronary blood flow velocities in the distal LAD by 
transthoracic  echocardiography.  He  compared  patients  with  significant  LAD  stenosis  and 
patients without stenosis and found that  there was no significant change in peak and mean 
diastolic blood flow velocity in these two groups.
Thomas Theiunissen et al. made assessment of coronary artery stenosis in patients at 
risk by TEE. In this study the normal blood flow velocities (in cm/sec) were 38 ± 11 and 79 ± 
19  in  LMCA during  systole  and diastole  respectively  and 36 ±  11  and 67 ±  19  in  LAD. 
Turbulence was the indicative of significant upstream stenosis. In this study the maximal to 
prestenotic velocity ratio was taken as Doppler criteria for significant stenosis. Pulsed doppler 
interogation  of  upstream  of  the  zone  of  turbulence  (Prestenotic  area)  demonstrated  peak 
diastolic  flow velocity  of  0.47  m/sec.  Velocities  at  the  site  of  aliasing  or  turbulence  was 
significantly increased with peak diastolic velocity of 1.4 m/sec. The maximal to prestenotic 
blood flow velocity ratio was >2.9 indicative of stenosis.
In our study there was significant turbulence with coronary flow velocity more than 1 m/
sec in 17 patients 6 of 17 in the left main and 11 of 17 in the proximal LAD.
This  is  in  contrast  to  Hutchison  Stuart  J  et  al. who  found  the  basal  mean  flow 
velocities were greater only in left main ostial stenosis than in proximal or mid LAD stenosis 
and the basal flow velocities in the proximal LAD stenosis was lesser than that of mid LAD 
stenosis.
Non invasive echocardiographic measurement of coronary flow velocity also enable to 
differentiate TIMI 3 flow from TIMI-2 coronary reperfusion in patients with acute myocardial 
infarction before coronary intervention.
Souki Lee et al. evaluate coronary flow velocity in 46 consecutive patients with acute 
anterior wall myocardial infarction. Echocardiography and subsequent coronary angiography 
done  in  all  the  patients.  LAD flow was  present  in  both  TIMI 3  and TIMI-2  groups.  The 
diastolic flow velocity, peak distal flow velocities were significantly higher in patients with 
TIMI 3 flow and concluded better antegrade flow by colour Doppler. Less reduced antegrade 
flow velocity by pulsed Doppler in patients with TIMI 3 flow in acute anterior myocardial 
infarction which enabled non invasive differentiation of TIMI 3 flow from TIMI 2 flow in 
patients with acute myocardial infarction.
Iwakura Katsuomi et al.  measured coronary flow velocity after myocardial contrast 
echocardiography. He found peak flow velocities and duration during systole were significantly 
lesser in patients with no reflow than those with reflow. Early systolic retrograde flow was 
frequently observed in patients with no flow but peak diastolic flow velocities were similar 
between these two subsets.
In our study both systolic and diastolic blood flow velocities were significantly reduced 
in 30 of 79 patients with acute anterior wall myocardial infarction. The possibility of TIMI 2 or 
slow flow could be assumed in these patients.
The detection of atherosclerotic aortic plaque by TEE and its significance and limitation 
as a marker of coronary artery disease was assessed by Yoshihisa Matsuma et al. The criteria 
used to  diagnose atherosclerotic  plaque on TEE were  the  presence  of  focally  and linearly 
increased echo density of the aortic intima with presence of plaque. He studied 84 patients who 
had undergone coronary angiogram previously. The plaques were detected in 93% of patients 
with coronary artery disease and 53% of patients without CAD.
Magdy F Ismaeil et al. defined plaque as simple lesion where the intimal thickness less 
than 5mm and complex lesion where the thickness more than 5mm with raised protruding echo 
dense plaque within the lumen. 49 of 60 patients (82%) included in his study population had 
significant CAD. Among patients with CAD, 82% of patients with single vessel disease, 89% 
of  patients  with double  vessel  disease  and 100% of  patients  with three  vessel  disease  had 
significant plaque in their aorta.
Tribouilloy  C et  al. retrospectively  analysed 105 consecutive patients  with valvular 
heart  disease  to  assess  the  value  of  TEE detection of  thoracic  aortic  plaque for  predicting 
coronary artery disease. In 19 patients with significant coronary artery stenosis, 18 had thoracic 
aortic  plaque by  TEE study.  In  contrast  aortic  plaque existed  in  only  10  of  remaining  86 
patients with normal coronary arteries or mildly atherosclerotic coronary lesions. There was a 
close relation between the degree of intimal changes and severity of CAD. In this study, the 
multivariable analysis of patient’s age, sex, risk factor of cardiovascular disease, angina and 
TEE  findings  revealed  that  atherosclerotic  plaque  was  the  most  significant  independent 
predictor of CAD.
According to Khoury Z et al the frequency, distribution, and severity of thoracic aortic 
plaques  were  evaluated  by  transesophageal  echocardiography  in  152  consecutive  patients 
undergoing coronary arteriography. Coronary artery disease was defined as ≥ 50% stenosis of ≥ 
1 major branch. Atherosclerotic plaques were detected in the aorta in 90 of the 97 patients 
(93%) with CAD,  but  in  only  12 of  the  55  patients  (22%) with  normal  coronary  arteries. 
Atherosclerotic  plaques in patients with CAD were found predominantly in the descending 
aorta (in 93%) and been in the aortic arch (in 80%), whereas the ascending aorta was the least 
involved (in 37%). In the descending aorta, 58% of the plaques were complex (>3 mm thick, 
ulcerated, mobile, or calcified), and in the aortic arch, 40% of the plaques were so calcified. 
Complex plaques were not found in the ascending aorta.
GP Fazio  et  al,  in  his  41  of  the  61  patients,  obstructive  CAD  was  detected  by 
angiography in at least one vessel (> 50% left main coronary artery stenosis or > 70% stenosis 
in the left anterior descending, right coronary or left circumflex artery distribution). In 37 of the 
41, atherosclerotic plaque was detected in the thoracic aorta by TEE. 20 of 61 patients had 
normal coronary angiographic findings or non obstructive lumen irregularities. In 2 of these 20 
patients, plaque was detected in the thoracic aorta by TEE. The presence of aortic plaque by 
TEE study had a  sensitivity  of  90% and a  specificity  of  90% for  angiographically  proved 
obstructive  coronary  artery  disease.  The  positive  predictive  value  of  aortic  plaque  for 
obstructive CAD was 95% and the negative predictive value was 82%. Hence he concluded 
that the detection of atherosclerotic plaque in the thoracic aorta by TEE appears to be a marker 
for the identification of obstructive coronary artery disease and deserves further investigation.
Yoshihisa Matsuma et al, Magdy F Ismaeil et al, Khoury Z et al , GP Fazio et al and 
others found a strong association between aortic plaque and CAD, but in our study though we 
could find increased percentage of patients showed plaque in descending thoracic aorta there 
was  no  statistically  significant  correlation  between  the  presence  of  aortic  plaque  and 
angiographically proved CAD. This was similar to the conclusion by Irene Meissner et al, and 
Bijoy K. Khandheria et al, who could not find aortic plaque as an independent risk factor for 
CAD.  
CONCLUSION
1. Transesophageal echocardiography is a promising and effective non invasive diagnostic 
method  of  visualizing  and  measuring  the  size  of  proximal  left  coronary  artery  in 
patients with coronary artery disease.
2. TEE could  visualize  the  LM in  all  the  patients  (100%).  By  TEE we can  visualize 
proximal LAD and proximal LCX in 93% and 87% respectively.
3. Patients with acute AWMI who had unsuccessful  thrombolysis showed significantly 
low  coronary  blood  flow  velocity  by  TEE  compared  to  successfully  thrombolysed 
group who had relatively higher coronary flow.  
4. Patients  with  LM  and  proximal  LAD  narrowing  diagnosed  by  TEE  showed 
angiographic correlation with coronary narrowing in CAG. 
5. Descending thoracic aortic plaque was present in 76% of patients with acute AWMI. 
There was no statistically significant correlation between the presence of plaque and the 
degree of presence and severity of CAD.
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ABBREVIATIONS
ACS Acute Coronary Syndrome
AMI      Acute Myocardial Infarction
AWMI   Anterior Wall Myocardial Infarction
CAD                  Coronary Artery Disease
CBFV                    Coronary Blood Flow Velocity
CFR Coronary Flow Reserve
CFV        Coronary Flow Velocity 
FFR Fractional Flow Reserve
LAD        Left Anterior Descending Artery
LCA       Left Coronary Artery
LCX         Left Circumflex Artery
LM          Left Main
RCA       Right Coronary Artery
SAX Short Axis  
TEE          Transesophageal echocardiography
PROFORMA

